In Vitro & In Vivo Diagnostic Substances · DE · CIK 874716
IDEXX LABORATORIES INC /DE provides products and services for animal health, water, and livestock/poultry/diagnostics
Comparable business profile · signals at a glance
In the 90 days to Mar 3, 2026: 5 sold $29.9M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 3, 2026 | Hunt NimrataExecutive Vice President | Sell | 1,758 | $634.57 | $1.1M |
| Feb 26, 2026 | Mazelsky Jonathan JayPresident and CEO | Sell | 3,660 | $658.92 | $2.4M |
| Feb 26, 2026 | Mazelsky Jonathan JayPresident and CEO | Sell | 2,859 | $659.75 | $1.9M |
| Feb 26, 2026 | Mazelsky Jonathan JayPresident and CEO | Sell | 2,860 | $657.84 | $1.9M |
| Feb 26, 2026 | Hunt NimrataExecutive Vice President | Sell | 2,693 | $661.54 | $1.8M |
| Feb 26, 2026 | Mazelsky Jonathan JayPresident and CEO | Sell | 2,589 | $663.04 | $1.7M |
| Feb 26, 2026 | Mazelsky Jonathan JayPresident and CEO | Sell | 1,669 | $652.49 | $1.1M |
| Feb 26, 2026 | Mazelsky Jonathan JayPresident and CEO | Sell | 1,488 | $655.85 | $976K |
| Feb 26, 2026 | Mazelsky Jonathan JayPresident and CEO | Sell | 1,343 | $656.85 | $882K |
| Feb 26, 2026 | Mazelsky Jonathan JayPresident and CEO | Sell | 1,281 | $650.67 | $834K |
| Feb 26, 2026 | Mazelsky Jonathan JayPresident and CEO | Sell | 1,200 | $661.10 | $793K |
| Feb 26, 2026 | Mazelsky Jonathan JayPresident and CEO | Sell | 1,171 | $653.68 | $765K |
| Feb 26, 2026 | Mazelsky Jonathan JayPresident and CEO | Sell | 1,111 | $654.63 | $727K |
| Feb 26, 2026 | Mazelsky Jonathan JayPresident and CEO | Sell | 1,095 | $651.49 | $713K |
| Feb 26, 2026 | Mazelsky Jonathan JayPresident and CEO | Sell | 1,000 | $662.16 | $662K |
| Feb 17, 2026 | Erickson Michael GExecutive Vice President | Sell | 2,694 | $628.22 | $1.7M |
| Feb 17, 2026 | Erickson Michael GExecutive Vice President | Sell | 1,288 | $626.26 | $807K |
| Feb 17, 2026 | Vandebroek Sophie V.Director | Sell | 945 | $628.65 | $594K |
| Feb 17, 2026 | Erickson Michael GExecutive Vice President | Sell | 689 | $629.09 | $433K |
| Feb 17, 2026 | Vandebroek Sophie V.Director | Sell | 519 | $628.56 | $326K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Coverage (30d): 6 reputable articles.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗